Pharmaceutical

Spectrum Pharmaceuticals Presents Late-Breaking Oral Presentation of Poziotinib Data in First-Line NSCLC Patients with Exon 20 HER2 Insertion Mutations at ESMO 2021

Initial data from cohort 4 of the ongoing ZENITH20 clinical trial show 44% ORR in 48 first-line patients treated with 16 mg poziotinib once daily HENDERSON, Nevada, September 18, 2021– (BUSINESS WIRE) – Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company specializing in innovative and targeted oncology therapies, today announced …

Read More »

Catalent signs commercial supply agreement with Phathom Pharmaceuticals

Catalent, the world’s leading provider of development science and drug manufacturing platforms, including biotherapeutics; cell and gene therapies; and consumer health products, today announced that it has signed a commercial supply agreement with Phathom Pharmaceuticals, an advanced clinical biopharmaceutical company focused on the development and commercialization of novel treatments for …

Read More »

Brokers Offer Profits For Biohaven Pharmaceutical Holding Company Ltd. for fiscal year 2022 (NYSE: BHVN)

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) – Cantor Fitzgerald equity researchers increased their earnings per share (EPS) estimate for fiscal 2022 for Biohaven Pharmaceutical in a research report released to customers and investors on Monday, September 13. Cantor Fitzgerald analyst C. Duncan now predicts the company will post earnings …

Read More »

ISA Pharmaceuticals begins treatment of patients in a third phase 2 clinical trial with the combination of ISA101b and Libtayo® (cemiplimab)

OEGSTGEEST, Netherlands, September 8, 2021 / PRNewswire / – ISA Pharmaceuticals BV, a clinical-stage biotechnology company, announces the start of patient dosing in a pivotal clinical trial of the combination of ISA101b and Libtayo® (cemiplimab) in advanced cancer of the HPV16 positive oropharynx. This new study is the third with …

Read More »

Dr. Reddy’s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to the anticancer agent E7777 (denileukine diftitox)

HYDERABAD, India & PRINCETON, NJ – (COMMERCIAL THREAD) – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, and its subsidiaries collectively referred to as “Dr. Reddy’s”), have announced that they have entered into a definitive agreement with Citius Pharmaceuticals, Inc. (“Citius”) under from which it sold …

Read More »

Form 6-K TAKEDA PHARMACEUTICAL For: 01 Sep.

News and research before you hear about it on CNBC et al. Claim your 1-week free trial for StreetInsider Premium here. FORM 6-K AMERICAN SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Foreign private issuer report In accordance with article 13a-16 or 15d-16 of the 1934 Stock Exchange Act For the …

Read More »

Camber Pharmaceuticals opens new headquarters

Camber’s new headquarters and distribution facility in Piscataway, New Jersey are now operational. Many of the Camber team have moved into the new building, products are being prepared for shipment and distribution from the new center will begin this fall. Camber now has 2 locations in Piscataway, as well as …

Read More »